Ruchira Glaser, MD, MS Clin Epi Biostatistics’ Post

Talking AI with Sanjay Doddamani, Guidehealth, Jim Chen, MD and Alti Rahman, American Oncology Network, At #COA2024, community oncology alliance annual meeting, session on “Is AI Ready for Prime Time for Cancer Care?”

Dr. Vernon Sondak talks about how critically important the data from clinical trials are in shaping new standards of care and in developing better treatment options for cancer patients. __________________________________________________ 🔬 Don't miss out on the latest developments in oncology! Let us show you how we can get the insights you need, from the HCPs you want to hear from - even during busy congress season! #immunotherapy #neoadjuvanttherapy #ClinicalTrials #ESMO24

Tremendous advances are made every day in the fight against cancer, but many promising treatments are costly, placing patients under enormous financial pressure that threatens their ability to achieve optimal outcomes.    In our recent case study, we examine the very real impact of high cost of care on cancer patients, how treatment in an independent practice can relieve financial burdens, and the benefits beyond cost that independent cancer centers provide.    Read it now:   #CostOfCare #CancerCare #CommunityOncology https://lnkd.in/gS3MGqh3

We are heading to #EHA2024 with our primary ambition to get in front of cancer!! Connect with Iva Yanakieva for an exploratory onsite meeting between June 12 and June 16 to learn more about our #CareerOpportunities in #Oncology #MedicalAffairs, #MarketAccess, #Marketing or within #Research & #Development space!

If you are attending #EHA2024 connect with Iva Yanakieva for an exploratory onsite meeting between June 12 and June 16 to learn more about our career opportunities, and how you can join our winning team! #MarketAccess #Hematology #Oncology

The precision medicine industry is continuously evolving, increasing the amount of available data. Without an effective way to filter and apply this data, it loses its potential to yield powerful results for patient care. Built with the capabilities that allow you to keep up with, navigate through, and analyze this ever-expanding information, GenomOncology's flexible solution suite can strengthen your workflows and processes, resulting in more comprehensible, efficient cancer care. Learn more about our precision oncology solutions today: https://ow.ly/NgT350Qyo4z #precisiononcology #precisionmedicine

🚨 Discover how DEI efforts enhance lung cancer care with our experts! Learn to tailor care plans reflecting patient preferences and values, and confidently apply DEI principles for better outcomes. 🌍 http://ms.spr.ly/6045l5PY1

🔬 Day four at the 2024 ASCO Annual Meeting! It’s great to be here and engage in transformative discussions with industry leaders and oncology professionals. Excited to (re)connect and absorb insights that drive cancer care forward. Attendees are invited to book a meeting with us today and hear more on a decade's worth of breakthroughs in global patient access, courtesy of Karlijn Doorn, PhD and Daniele Tagliente. https://lnkd.in/epdyrvHn From pioneering expanded access programs (#EAPs) to harnessing real-world data (#RWD), we're here to revolutionize access and participation in clinical trials. We're open to discussions about collaborations that leave a lasting impact. #ASCO2024 #Oncology #RealWorldData #ExpandedAccess

🚀 Digital Oncology is Much More than ePROs to Deliver Comprehensive Care Explore how healthcare providers can harness the power of AI, remote monitoring, and more to provide personalized, efficient, and comprehensive support for cancer patients. The exclusive roundtable discussion features expert insights from Andrew Norden, MD (OncoHealth) and Chet Robson, (Jasper Health). Register Now ➡️ https://lnkd.in/e7BkPiZ3 Key topics include: ✨ Integrating a diverse array of digital tools beyond just ePROs into oncology care pathways ✨ Addressing challenges and opportunities with widespread adoption of digital oncology solutions ✨ Enhancing interdisciplinary collaboration through seamless digital integration for improved patient outcomes Don't miss this chance to learn about the future of digital oncology! #DigitalHealth #OncologyCare #HLTH

📣 2023 was a break-out year for OneOncology, as our latest annual report showcases. 🥁 Inside our 2023 annual report, you'll learn about how we reached a $2.1 billion valuation in under 5 years. 📈 You'll read about the impressive growth OneOncology realized by adding practices to the platform, and by helping our partners grow their practices locally by adding physicians and services along the cancer care continuum. 🎯 The report details the clinical technology and innovation OneOncology has brought forward to make it easier for our physician partners to practice high-quality care. ⚙ And the report highlights the services we're centralizing to create efficiencies for our partners. 💬 As CEO Jeff Patton, MD writes in his opening letter: 2023 was a year of validation for OneOncology and our business model. ⤵ Click on the report to read it, and drop us a line with your thoughts. ⤵ https://lnkd.in/ebHp5Q9y